Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
Zainab M. Elsayed, Hadia Almahli, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity
Samah Higazy, Nermin Samir, Ahmed El‐Khouly, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107089-107089
Closed Access | Times Cited: 10
Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity
Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, Simone Giovannuzzi, et al.
International Journal of Biological Macromolecules (2025), pp. 140462-140462
Closed Access
A Systematic Review of Synthetic and Anticancer and Antimicrobial Activity of Quinazoline/Quinazolin‐4‐one Analogues
Neha Manhas, Gobind Kumar, Sanjeev Dhawan, et al.
ChemistryOpen (2025)
Open Access
Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer
Wagdy M. Eldehna, Eslam Essam Mohammed, Ghada H. Al-Ansary, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115538-115538
Closed Access | Times Cited: 16
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 16
Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors
Wagdy M. Eldehna, Zainab M. Elsayed, Andrea Ammara, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135010-135010
Closed Access | Times Cited: 4
Synthesis of new class of non-sulfonamide bis-benzimidazoles as antitumor agents by inhibiting carbonic anhydrase-IX enzyme
Shakeel Ahmad Khan, Zarbad Shah, Syed Raza Shah, et al.
International Journal of Biological Macromolecules (2023) Vol. 255, pp. 128259-128259
Closed Access | Times Cited: 2
Isocoumarins incorporating chalcone moieties act as isoform selective tumor-associated carbonic anhydrase inhibitors
Mehmet Onyılmaz, Murat Koca, Andrea Ammara, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 13, pp. 1347-1355
Closed Access
Tetrazole Is a Novel Zinc Binder Chemotype for Carbonic Anhydrase Inhibition
Simone Giovannuzzi, Andrea Angeli, Paloma Begines, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 16, Iss. 1, pp. 163-166
Closed Access
Page 1

Scroll to top